Please login to the form below

Not currently logged in
Email:
Password:

Hugh Cole leaves Shire for Ariad

Appointed chief business officer at company behind Iclusig

Ariad, Hugh ColeHugh Cole has left his role at Shire to join Ariad Pharmaceuticals as chief business officer.

In this role Cole will report to CEO Dr Harvey Berger and will be responsible for the company's global business and corporate development, licensing and strategic planning.

Cole spent seven years at Shire, most recently as senior VP, strategic planning and programme management. Prior to this he was a global franchise lead and VP, business development.

At Shire he gained experience in the orphan drugs market, which will benefit Ariad as it prepares to grow its portfolio of drugs targeted to treat rare, difficult-to-treat forms of cancer.

This includes its only current marketed product Iclusig, which is recommended to treat chronic myeloid leukaemia and T315I-positive Philadelphia chromosome positive acute lymphoblastic leukaemia.

The appointment of a chief business officer is a sign of confidence from Ariad, which last year faced safety concerns about Iclusig, but has since seen the drug backed by both the EMA and the FDA, although with new safety recommendations.

CEO Berger said: “[Cole] will be integral in seeking business and corporate development opportunities for Ariad, including a commercial partnership for Iclusig in Japan, as well as helping to further maximise our oncology pipeline.”

8th April 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics